EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial

Miao Yu iD, Yong Yang iD, Si-Lai Dong iD, Chen Zhao iD, Fen Yang iD, Yuan-Fan Yuan iD, Yu-Hua Liao iD, Shao-Lin He iD, Kun Liu iD, Fen Wei, Hai-Bo Jia iD, Bo Yu iD und 1 weitere

Circulation · 24.09.2024 · 150 (13) · 981-993

DOI: 10.1161/circulationaha.124.069808 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 24.09.2024. Verfasst von Miao Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (M.Y., Y.Y., S.-L.D., F.Y., Y.-F.Y., Y.-H.L., S.-L.H., K.L., F.W., X.C.), Union Hospital, Tongji Medical College, Huazhong U…. Hauptthemen laut MEDLINE: Colchicine, Acute Coronary Syndrome, Tomography, Optical Coherence, Plaque, Atherosclerotic. Die Arbeit wurde bisher 122-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Colchicine has been approved to reduce cardiovascular risk in patients with coronary heart disease on the basis of its potential benefits demonstrated in the COLCOT (Colchicine Cardiovascular Outcomes Trial) and LoDoCo2 (Low-Dose Colchicine 2) studies. Nevertheless, there are limited data available about the specific impact of colchicine on coronary plaques. METHODS: This was a prospective, single-center, randomized, double-blind clinical trial. From May 3, 2021, until August 31, 2022, a total of 128 patients with acute coronary syndrome aged 18 to 80 years with lipid-rich plaque (lipid pool arc >90°) detected by optical coherence tomography were included. The subjects were randomly assigned in a 1:1 ratio to receive either colchicine (0.5 mg once daily) or placebo for 12 months. The primary end point was the change in the minimal fibrous cap thickness from baseline to the 12-month follow-up. RESULTS: Among 128 patients, 52 in the colchicine group and 52 in the placebo group completed the study. The mean age of the 128 patients was 58.0±9.8 years, and 25.0% were female. Compared with placebo, colchicine therapy significantly increased the minimal fibrous cap thickness (51.9 [95% CI, 32.8 to 71.0] μm versus 87.2 [95% CI, 69.9 to 104.5] μm; difference, 34.2 [95% CI, 9.7 to 58.6] μm; P =0.006), and reduced average lipid arc (–25.2° [95% CI, –30.6° to –19.9°] versus –35.7° [95% CI, –40.5° to –30.8°]; difference, –10.5° [95% CI, –17.7° to –3.4°]; P =0.004), mean angular extension of macrophages (–8.9° [95% CI, –13.3° to –4.6°] versus –14.0° [95% CI, –18.0° to –10.0°]; difference, –6.0° [95% CI, –11.8° to –0.2°]; P =0.044), high-sensitivity C-reactive protein level (geometric mean ratio, 0.6 [95% CI, 0.4 to 1.0] versus 0.3 [95% CI, 0.2 to 0.5]; difference, 0.5 [95% CI, 0.3 to 1.0]; P =0.046), interleukin-6 level (geometric mean ratio, 0.8 [95% CI, 0.6 to 1.1] versus 0.5 [95% CI, 0.4 to 0.7]; difference, 0.6 [95% CI, 0.4 to 0.9]; P =0.025), and myeloperoxidase level (geometric mean ratio, 1.0 [95% CI, 0.8 to 1.2] versus 0.8 [95% CI, 0.7 to 0.9]; difference, 0.8 [95% CI, 0.6 to 1.0]; P =0.047). CONCLUSIONS: Our findings suggested that colchicine resulted in favorable effects on coronary plaque stabilization at optical coherence tomography in patients with acute coronary syndrome. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04848857.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColchicineAcute Coronary SyndromeTomography, Optical CoherencePlaque, AtheroscleroticHumansFemaleMiddle AgedMaleDouble-Blind MethodAgedProspective StudiesAdultTreatment OutcomeCoronary Artery Disease

Stichwörter der Autor:innen

acute coronary syndromescolchicineinflammationoptical coherence tomography

Substanzen

Colchicine

Autor:innen und Institutionen

  • Department of Cardiology (M.Y., Y.Y., S.-L.D., F.Y., Y.-F.Y., Y.-H.L., S.-L.H., K.L., F.W., X.C.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Hubei Key Laboratory of Biological Targeted Therapy (M.Y., Y.Y., S.-L.D., F.Y., Y.-F.Y., Y.-H.L., S.-L.H., K.L., F.W., X.C.), Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan,…
  • Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases (M.Y., Y.Y., S.-L.D., F.Y., Y.-F.Y., Y.-H.L., S.-L.H., K.L., F.W., X.C.), Union Hospital, Tongji Medical Co…
  • Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, China (C.Z., H.-B.J., B.Y.).
  • National Key Laboratory of Frigid Zone Cardiovascular Diseases, Harbin, China (C.Z., H.-B.J., B.Y.).
  • Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin (C.Z., H.-B.J., B.Y.).

ORCID-Profile: Miao Yu, Yong Yang, Si-Lai Dong, Chen Zhao, Fen Yang, Yuan-Fan Yuan, Yu-Hua Liao, Shao-Lin He, Kun Liu, Hai-Bo Jia, Bo Yu, Xiang Cheng

Zitieren

APA

Yu, M., Yang, Y., Dong, S. L., Zhao, C., Yang, F., Yuan, Y. F., Liao, Y. H., He, S. L., Liu, K., Wei, F., Jia, H. B., Yu, B., & Cheng, X. (2024). Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial. Circulation, 150(13), 981-993. https://doi.org/10.1161/circulationaha.124.069808

Vancouver

Yu M, Yang Y, Dong SL, Zhao C, Yang F, Yuan YF, et al. Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial. Circulation. 2024;150(13):981-993. doi:10.1161/circulationaha.124.069808

BibTeX
@article{Yu2024,
  author = {Yu, Miao and Yang, Yong and Dong, Si-Lai and Zhao, Chen and Yang, Fen and Yuan, Yuan-Fan and Liao, Yu-Hua and He, Shao-Lin and Liu, Kun and Wei, Fen and Jia, Hai-Bo and Yu, Bo and Cheng, Xiang},
  title = {Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {13},
  pages = {981--993},
  doi = {10.1161/circulationaha.124.069808}
}
Kostenlos starten →